BIOMERICA INC Share-based Payment Arrangement, Expense
BIOMERICA INC (BMRA) reported Share-based Payment Arrangement, Expense of $58.00 thousand for the 3-month period ending 2026-02-28, per its 10-Q filed 2026-04-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-04-13
- BIOMERICA INC share-based payment arrangement, expense for the quarter ending 2026-02-28 was $58.00K, a 36.26% decline year-over-year.
- BIOMERICA INC share-based payment arrangement, expense for the quarter ending 2025-11-30 was $72.00K, a 53.55% decline year-over-year.
- BIOMERICA INC share-based payment arrangement, expense for the quarter ending 2025-08-31 was $74.00K, a 3.90% decline year-over-year.
- BIOMERICA INC share-based payment arrangement, expense for the quarter ending 2025-05-31 was $137.00K, a 32.84% decline year-over-year.
- BIOMERICA INC share-based payment arrangement, expense for fiscal 2025 was $460.00K, a 45.04% decline from fiscal 2024.
- BIOMERICA INC share-based payment arrangement, expense for fiscal 2024 was $837.00K, a 29.37% decline from fiscal 2023.
- BIOMERICA INC share-based payment arrangement, expense for fiscal 2023 was $1.19M, a 5.95% decline from fiscal 2022.
- BIOMERICA INC share-based payment arrangement, expense for fiscal 2022 was $1.26M, a 7.01% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2026-02-28 | $58.00K 10-Q · filed 2026-04-13 | $130.00K derived: sum of 2 quarters · filed 2026-04-13 | $204.00K 10-Q · filed 2026-04-13 | $341.00K derived: sum of 4 quarters · filed 2026-04-13 | |
| 2025-11-30 | $72.00K 10-Q · filed 2026-01-14 | $145.00K 10-Q · filed 2026-01-14 | $283.00K derived: sum of 3 quarters · filed 2026-01-14 | $374.00K derived: sum of 4 quarters · filed 2026-04-13 | |
| 2025-08-31 | $74.00K 10-Q · filed 2025-10-14 | $211.00K derived: sum of 2 quarters · filed 2025-10-14 | $302.00K derived: sum of 3 quarters · filed 2026-04-13 | $457.00K derived: sum of 4 quarters · filed 2026-04-13 | |
| 2025-05-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $228.00K derived: sum of 2 quarters · filed 2026-04-13 | $383.00K derived: sum of 3 quarters · filed 2026-04-13 | $460.00K 10-K · filed 2025-08-29 | |
| 2025-02-28 | $91.00K 10-Q · filed 2026-04-13 | $246.00K derived: sum of 2 quarters · filed 2026-04-13 | $323.00K 10-Q · filed 2026-04-13 | $527.00K derived: sum of 4 quarters · filed 2026-04-13 | |
| 2024-11-30 | $155.00K 10-Q · filed 2026-01-14 | $232.00K 10-Q · filed 2026-01-14 | $436.00K derived: sum of 3 quarters · filed 2026-01-14 | $776.00K derived: sum of 4 quarters · filed 2026-01-14 | |
| 2024-08-31 | $77.00K 10-Q · filed 2025-10-14 | $281.00K derived: sum of 2 quarters · filed 2025-10-14 | $621.00K derived: sum of 3 quarters · filed 2025-10-14 | $743.00K derived: sum of 4 quarters · filed 2025-10-14 | |
| 2024-05-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $544.00K derived: sum of 2 quarters · filed 2025-08-29 | $666.00K derived: sum of 3 quarters · filed 2025-08-29 | $837.00K 10-K · filed 2025-08-29 | |
| 2024-02-29 | $340.00K 10-Q · filed 2025-04-14 | $462.00K derived: sum of 2 quarters · filed 2025-04-14 | $633.00K 10-Q · filed 2025-04-14 | $811.00K derived: sum of 4 quarters · filed 2025-04-14 | |
| 2023-11-30 | $122.00K 10-Q · filed 2025-01-14 | $292.00K 10-Q · filed 2025-01-14 | $471.00K derived: sum of 3 quarters · filed 2025-01-14 | $854.83K derived: sum of 4 quarters · filed 2025-01-14 | |
| 2023-08-31 | $170.00K 10-Q · filed 2024-10-15 | $349.00K derived: sum of 2 quarters · filed 2024-10-15 | $732.83K derived: sum of 3 quarters · filed 2024-10-15 | $1.05M derived: sum of 4 quarters · filed 2024-10-15 | |
| 2023-05-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $562.83K derived: sum of 2 quarters · filed 2024-08-28 | $881.06K derived: sum of 3 quarters · filed 2024-08-28 | $1.19M 10-K · filed 2024-08-28 | |
| 2023-02-28 | $383.83K 10-Q · filed 2023-04-14 | $702.06K derived: sum of 2 quarters · filed 2023-04-14 | $1.01M 10-Q · filed 2024-04-12 | ||
| 2022-11-30 | $318.23K 10-Q · filed 2023-04-14 | $622.00K 10-Q · filed 2024-01-16 | |||
| 2022-08-31 | $304.00K 10-Q · filed 2023-10-12 | $303.75K 10-Q · filed 2022-10-13 | |||
| 2022-05-31 | $1.26M 10-K · filed 2023-08-25 | ||||
| 2022-02-28 | $325.35K 10-Q · filed 2023-04-14 | $639.75K derived: sum of 2 quarters · filed 2023-04-14 | $959.37K derived: sum of 3 quarters · filed 2023-04-14 | ||
| 2021-11-30 | $314.40K 10-Q · filed 2023-04-14 | $634.02K derived: sum of 2 quarters · filed 2023-04-14 | |||
| 2021-08-31 | $319.62K 10-Q · filed 2023-04-14 | ||||
| 2021-05-31 | $1.35M 10-K · filed 2022-08-29 | ||||
| 2019-05-31 | $151.22K 10-K · filed 2019-08-29 | ||||
| 2018-05-31 | $18.47K 10-K · filed 2019-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |